{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T01:13:12Z","timestamp":1747185192593,"version":"3.40.5"},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Our aim was to assess if switching from a protease inhibitors (PI)\u2010based regimen to a PI\u2010free one is associated with an increased risk of Kaposi Sarcoma (KS) relapse among patients living with HIV (PLHIV) with history of KS and controlled HIV replication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a retrospective analysis of the prospectively collected Dat\u2019AIDS database we selected patients who both had a past KS history and a HIV\u20101 viral load below 200 copies\/mL while being PI\u2010treated. We searched for KS relapses while persistent virological success was maintained for at least 6 months, whether patients kept taking the PI, or switched to PI\u2010free regimen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 216 patients with past KS event and a history of HIV\u20101 infection efficiently treated by a PI\u2010based regimen, 148 patients (68.5%) later switched to a PI\u2010sparing regimen. Their baseline characteristics were not different from non\u2010switching patients. We described 7 cases of relapse (3.2% of the 216 patients). Five cases of relapse occurred in switching patients (3.4%). The remaining two relapses occurred in PI\u2010treated patients (2.9%). At KS relapse, CD4 cell count was 459 cells\/\u03bcL (range 225\u2013560) for switching patients, compared with 362 and 136 cells\/\u03bcL for the other two patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this large cohort of PLHIV with a history of KS and ART\u2010controlled HIV replication, KS relapses were described in 3.2% of the patients, and were not more frequent when a PI\u2010containing ART regimen has been switched to a PI\u2010free regimen. Our results do not support a specific effect of PI on KS.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.13168","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T11:53:13Z","timestamp":1634817193000},"page":"301-306","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["No increased risk of Kaposi sarcoma relapse in patients with controlled HIV\u20101 infection after switching protease inhibitor\u2010based antiretroviral therapy"],"prefix":"10.1111","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1570-9429","authenticated-orcid":false,"given":"R\u00e9becca","family":"Lajaunie","sequence":"first","affiliation":[{"name":"Department of Infectious and Tropical Diseases Toulouse University Hospital  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6345-497X","authenticated-orcid":false,"given":"Lise","family":"Cuzin","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases Martinique University Hospital Fort de France FWI and INSERM UMR 1027 Toulouse III University  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Palich","sequence":"additional","affiliation":[{"name":"Sorbonne University Infectious Diseases Department Piti\u00e9\u2010Salp\u00eatri\u00e8re Hospital AP\u2010HP Pierre Louis Epidemiology and Public Health Institute (iPLESP) INSERM 1136  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-8444","authenticated-orcid":false,"given":"Alain","family":"Makinson","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases Montpellier University Hospital InsermU1175  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-866X","authenticated-orcid":false,"given":"Firouz\u00e9","family":"Bani\u2010Sadr","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases Reims University Hospital 45, rue Cognacq\u2010Jay \u2010 51092 Reims Cedex  Reims France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Duvivier","sequence":"additional","affiliation":[{"name":"AP\u2010HP Necker Hospital Infectious Diseases Department Necker\u2010Pasteur Infectiology Center; IHU Imagine; Universit\u00e9 de Paris; INSERM U1016 Institut Cochin; CNRS UMR8104; Institut Pasteur Medical Center of Institut Pasteur Necker\u2010Pasteur Infectiology Center  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cedric","family":"Arvieux","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases Rennes University Hospital 2 Rue Henri le Guilloux  Rennes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Rey","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases Strasbourg University Hospital  Strasbourg France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Poizot\u2010Martin","sequence":"additional","affiliation":[{"name":"Aix Marseille University INSERM IRD SESSTIM Sciences Economiques &amp; Sociales de la Sant\u00e9 &amp; Traitement de l\u2019Information M\u00e9dicale  Marseille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Delpierre","sequence":"additional","affiliation":[{"name":"Toulouse University Facult\u00e9 de M\u00e9decine 37 All\u00e9es Jules Guesde  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Delobel","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases Toulouse University Hospital and INSERM UMR1291 \u2010 CNRS UMR5051 \u2013 Universit\u00e9 Toulouse III Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity)  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Martin\u2010Blondel","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases Toulouse University Hospital and INSERM UMR1291 \u2010 CNRS UMR5051 \u2013 Universit\u00e9 Toulouse III Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity)  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"And The Dat\u2019AIDS study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1615896"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz762"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307040-00028"},{"key":"e_1_2_8_5_1","first-page":"6901","article-title":"Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor\u2010cell apoptosis associated with perturbation of proteasomal proteolysis","volume":"62","author":"Gaedicke S","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_8_6_1","first-page":"1405","article-title":"Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection","volume":"60","author":"Kowalkowski MA","year":"2015","journal-title":"Clin Infect Dis"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1479"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3771"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001588"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0302-225"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.11.037"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw562"},{"key":"e_1_2_8_13_1","first-page":"133","article-title":"Different impact of anti\u2010retroviral regimen containing protease inhibitors on development of HIV\u2010related Kaposi sarcoma","volume":"29","author":"Carleo MA","year":"2015","journal-title":"Vivo"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603056"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc070508"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282ff6275"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307250-00001"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17025"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00719.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.14.597"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1086\/507648"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.13168","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hiv.13168","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.13168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T19:35:39Z","timestamp":1692992139000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.13168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1111\/hiv.13168"],"URL":"https:\/\/doi.org\/10.1111\/hiv.13168","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"type":"print","value":"1464-2662"},{"type":"electronic","value":"1468-1293"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"2021-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}